This article first appeared on GuruFocus.
Exploring the Latest 13F Filing and Investment Shifts
Ken Fisher (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2026, providing insights into his investment moves during this period. Ken Fisher (Trades, Portfolio) is the Chief Executive Officer and Chief Investment Officer of Fisher Investments. He has been writing Forbes' prestigious "Portfolio Strategy" column for over two decades, making him one of the longest-running columnists in the magazine's 85+ year history. During his many years of money management and market commentary, Ken has distinguished himself by making numerous, accurate market calls, often in direct opposition to Wall Street's consensus forecast. He is the son of legendary investor Philip A. Fisher, and Ken is the only industry professional his father ever trained. Ken has also written three major finance books, including the 1984 Dow Jones best-seller, Super Stocks, and has been published and/or interviewed in many major global finance and business periodicals. The investment philosophy at Fisher Investments is based on the idea that supply and demand of securities is the sole determinant of their pricing. Furthermore, they believe that all widely known information has already been priced into the market. The way to add value, according to the Fisher strategy, is to "identify information not widely known, or to interpret widely known information differently and correctly from other market participants." Fisher Investments employs a team of research analysts to accomplish these tasks.
Warning! GuruFocus has detected 5 Warning Signs with NVDA. Is NVDA fairly valued? Test your thesis with our free DCF calculator.
Summary of New Buy
Ken Fisher (Trades, Portfolio) added a total of 117 stocks, among them:
The most significant addition was AstraZeneca PLC (NYSE:AZN), with 10,845,708 shares, accounting for 0.73% of the portfolio and a total value of $2.14 billion. The second largest addition to the portfolio was Portfolio Building Block World Pharma and Biotech Index ETF (NASDAQ:PBPH), consisting of 28,040,859 shares, representing approximately 0.24% of the portfolio, with a total value of $716.69 million. The third largest addition was Portfolio Building Block Integrated Oil and Gas and Exploration and Production Index ETF (NASDAQ:PBOG), with 19,066,831 shares, accounting for 0.23% of the portfolio and a total value of $675.89 million.
Key Position Increases
Ken Fisher (Trades, Portfolio) also increased stakes in a total of 415 stocks, among them:
Story Continues
The most notable increase was AbbVie Inc (NYSE:ABBV), with an additional 8,463,716 shares, bringing the total to 9,092,054 shares. This adjustment represents a significant 1,347% increase in share count, a 0.62% impact on the current portfolio, with a total value of $1.98 billion. The second largest increase was Pfizer Inc (NYSE:PFE), with an additional 53,012,321 shares, bringing the total to 104,964,427. This adjustment represents a significant 102.04% increase in share count, with a total value of $2.95 billion.
Summary of Sold Out
Ken Fisher (Trades, Portfolio) completely exited 116 of the holdings in the first quarter of 2026, as detailed below:
AstraZeneca PLC (NYSE:AZN): Ken Fisher (Trades, Portfolio) sold all 21,601,433 shares, resulting in a -0.68% impact on the portfolio. Trip.com Group Ltd (NASDAQ:TCOM): Ken Fisher (Trades, Portfolio) liquidated all 2,431,248 shares, causing a -0.06% impact on the portfolio.
Key Position Reduces
Ken Fisher (Trades, Portfolio) also reduced positions in 460 stocks. The most significant changes include:
Reduced Abbott Laboratories (NYSE:ABT) by 10,688,150 shares, resulting in a -93.43% decrease in shares and a -0.46% impact on the portfolio. The stock traded at an average price of $112.91 during the quarter and has returned -21.64% over the past 3 months and -30.34% year-to-date. Reduced Adobe Inc (NASDAQ:ADBE) by 3,836,949 shares, resulting in a -96.85% reduction in shares and a -0.46% impact on the portfolio. The stock traded at an average price of $277.01 during the quarter and has returned -6.79% over the past 3 months and -28.52% year-to-date.
Portfolio Overview
At the first quarter of 2026, Ken Fisher (Trades, Portfolio)'s portfolio included 1,015 stocks, with top holdings including 5.24% in NVIDIA Corp (NASDAQ:NVDA), 4.86% in Apple Inc (NASDAQ:AAPL), 4.76% in iShares 7-10 Year Treasury Bond ETF (NASDAQ:IEF), 3.81% in Alphabet Inc (NASDAQ:GOOGL), and 3.26% in Microsoft Corp (NASDAQ:MSFT).
The holdings are mainly concentrated in 10 of all the 11 industries: Technology, Financial Services, Industrials, Healthcare, Energy, Communication Services, Consumer Cyclical, Consumer Defensive, Basic Materials, and Real Estate.
View Comments
文章加载中…